MIRA Pharmaceuticals (MIRA) Stock Chart & Stock Price History $1.12 +0.09 (+8.74%) Closing price 04:00 PM EasternExtended Trading$1.08 -0.04 (-3.13%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MIRA Pharmaceuticals Stock Price Performance 5 Day Performance+12.65%1 Month Performance+5.66%3 Month Performance-1.75%6 Month Performance-35.26%Year-To-Date Performance-1.75%1 Year Performance+31.76% Receive MIRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address MIRA Stock Chart for Tuesday, April, 29, 2025 MIRA Chart by TradingView MIRA Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/29/2025$1.03$1.12+8.74%$1.15$1.03484,055 shs$18.83 million04/28/2025$1.04$1.03-0.96%$1.09$0.95313,935 shs$17.32 million04/25/2025$0.99$1.04+4.61%$1.08$0.98627,287 shs$17.49 million04/24/2025$0.92$0.99+7.95%$1.03$0.90697,645 shs$16.72 million04/23/2025$0.86$0.92+7.08%$0.99$0.844.78 million shs$15.49 million04/22/2025$0.87$0.86-0.57%$0.89$0.84296,936 shs$14.46 million04/21/2025$0.94$0.87-7.87%$0.94$0.86397,237 shs$14.54 million04/18/2025$0.94$0.94$0.99$0.831.81 million shs$15.79 million04/17/2025$1.07$0.94-12.25%$0.99$0.831.81 million shs$15.79 million04/16/2025$0.90$1.07+19.26%$1.33$0.9947.91 million shs$17.99 million Get the Latest News and Ratings for MIRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/15/2025$0.89$0.90+0.81%$0.90$0.8957,240 shs$15.09 million04/14/2025$0.86$0.89+2.90%$0.90$0.8788,493 shs$14.96 million04/11/2025$0.84$0.86+2.52%$0.89$0.8459,584 shs$14.54 million04/10/2025$0.85$0.84-0.17%$0.86$0.8257,293 shs$14.18 million04/09/2025$0.83$0.85+1.81%$0.87$0.7878,292 shs$14.21 million04/09/2025$0.83$0.85+1.81%$0.87$0.7878,292 shs$14.21 million04/08/2025$0.80$0.83+3.39%$0.87$0.81119,585 shs$13.96 million04/08/2025$0.80$0.83+3.39%$0.87$0.81119,585 shs$13.96 million04/07/2025$0.83$0.80-3.79%$0.84$0.73299,376 shs$13.50 million04/04/2025$0.90$0.83-7.29%$0.94$0.81134,324 shs$14.03 million04/03/2025$0.95$0.90-5.06%$0.97$0.87140,224 shs$14.91 million04/02/2025$0.96$0.95-0.73%$1.00$0.93160,646 shs$15.70 million04/01/2025$0.98$0.96-2.55%$1.00$0.95124,921 shs$15.82 million03/31/2025$1.06$0.98-7.55%$1.05$0.98173,446 shs$16.23 million03/28/2025$1.10$1.06-3.64%$1.11$1.0682,136 shs$17.56 million Related Companies PMV Pharmaceuticals Stock Chart Assertio Stock Chart Adverum Biotechnologies Stock Chart Kronos Bio Stock Chart Ikena Oncology Stock Chart Medicus Pharma Stock Chart Precision BioSciences Stock Chart BeyondSpring Stock Chart Milestone Pharmaceuticals Stock Chart FibroBiologics Stock Chart Receive MIRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MIRA) was last updated on 4/29/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MIRA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.